EUVIMEDEUVIMED entdecken
Open Access

Epithelial-derived interleukin-23 promotes oral mucosal immunopathology

Tae Sung Kim, Tomoko Ikeuchi, Vasileios Ionas Theofilou, Drake Winslow Williams, Teresa Greenwell-Wild, Armond June, Emmanuel E Adade, Lu Li, Loreto Abusleme, Nicolas Dutzan, Yao Yuan, Laurie Brenchley und 12 weitere

Immunity · 2024-04 · 57 (4) · 859-875.e11

DOI: 10.1016/j.immuni.2024.02.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2024-04. Verfasst von Tae Sung Kim und 23 weiteren Autor:innen. Beteiligte Einrichtung: Oral Immunity and Infection Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Interleukin-23, Periodontitis. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIDCD NIH HHS, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

At mucosal surfaces, epithelial cells provide a structural barrier and an immune defense system. However, dysregulated epithelial responses can contribute to disease states. Here, we demonstrated that epithelial cell-intrinsic production of interleukin-23 (IL-23) triggers an inflammatory loop in the prevalent oral disease periodontitis. Epithelial IL-23 expression localized to areas proximal to the disease-associated microbiome and was evident in experimental models and patients with common and genetic forms of disease. Mechanistically, flagellated microbial species of the periodontitis microbiome triggered epithelial IL-23 induction in a TLR5 receptor-dependent manner. Therefore, unlike other Th17-driven diseases, non-hematopoietic-cell-derived IL-23 served as an initiator of pathogenic inflammation in periodontitis. Beyond periodontitis, analysis of publicly available datasets revealed the expression of epithelial IL-23 in settings of infection, malignancy, and autoimmunity, suggesting a broader role for epithelial-intrinsic IL-23 in human disease. Collectively, this work highlights an important role for the barrier epithelium in the induction of IL-23-mediated inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-23PeriodontitisHumansEpithelial CellsInflammationToll-Like Receptor 5

Stichwörter der Autor:innen

IL-23Pseudomonas aeruginosaTLR5barrier immunityepithelialepithelial-intrinsicflagellinoral mucosapathogenic Th17periodontitis

Substanzen

Interleukin-23Toll-Like Receptor 5

Autor:innen und Institutionen

  • Oral Immunity and Infection Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.
  • Oral Immunity and Infection Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA; Department of Oncology and Diagnostic Sciences, School of Dentistry, U…
  • Department of Oral Biology, School of Dental Medicine, State University of New York at Buffalo, University at Buffalo, Buffalo, NY 14214, USA.
  • Department of Biological Sciences, University at Albany, State University of New York, Albany, NY 12210, USA.
  • Department of Pathology and Oral Medicine, Faculty of Dentistry, University of Chile, Santiago, Chile.
  • Department of Conservative Dentistry, Faculty of Dentistry, University of Chile, Santiago, Chile.

Förderung

  • Intramural NIH HHS
  • NIDCD NIH HHS
  • NIDCR NIH HHS
  • National Cancer Institute
  • National Institute on Deafness and Other Communication Disorders
  • National Institute of Dental and Craniofacial Research
  • National Institute of Allergy and Infectious Diseases
  • University of Chile

Zitieren

APA

Kim, T. S., Ikeuchi, T., Theofilou, V. I., Williams, D. W., Greenwell-Wild, T., June, A., Adade, E. E., Li, L., Abusleme, L., Dutzan, N., Yuan, Y., Brenchley, L., Bouladoux, N., Sakamachi, Y., NIDCD/NIDCR Genomics and Computational Biology Core, Palmer, R. J., Iglesias-Bartolome, R., Trinchieri, G., Garantziotis, S., …, & Moutsopoulos, N. M. (2024). Epithelial-derived interleukin-23 promotes oral mucosal immunopathology. Immunity, 57(4), 859-875.e11. https://doi.org/10.1016/j.immuni.2024.02.020

Vancouver

Kim TS, Ikeuchi T, Theofilou VI, Williams DW, Greenwell-Wild T, June A, et al. Epithelial-derived interleukin-23 promotes oral mucosal immunopathology. Immunity. 2024;57(4):859-875.e11. doi:10.1016/j.immuni.2024.02.020

BibTeX
@article{Kim2024,
  author = {Kim, Tae Sung and Ikeuchi, Tomoko and Theofilou, Vasileios Ionas and Williams, Drake Winslow and Greenwell-Wild, Teresa and June, Armond and Adade, Emmanuel E and Li, Lu and Abusleme, Loreto and Dutzan, Nicolas and Yuan, Yao and Brenchley, Laurie and Bouladoux, Nicolas and Sakamachi, Yosuke and NIDCD/NIDCR Genomics and Computational Biology Core, NIDCD/NIDCR Genomics and Computational Biology Core and Palmer, Robert J and Iglesias-Bartolome, Ramiro and Trinchieri, Giorgio and Garantziotis, Stavros and Belkaid, Yasmine and Valm, Alex M and Diaz, Patricia I and Holland, Steven M and Moutsopoulos, Niki M},
  title = {Epithelial-derived interleukin-23 promotes oral mucosal immunopathology},
  journal = {Immunity},
  year = {2024},
  volume = {57},
  number = {4},
  pages = {859--875.e11},
  doi = {10.1016/j.immuni.2024.02.020}
}
Kostenlos starten →